Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


PETERSON SCOTT ROBERT Create: Alert

All | News | Filings
Date FiledTypeDescription
03/13/2018 4 PETERSON SCOTT ROBERT (Chief Scientific Officer) has filed a Form 4 on Cascadian Therapeutics, Inc.
Txns: Unknown transaction of 3,639 shares @ $0
Disposed/sold 8,334 options to buy @ $19.92, valued at $166k
Disposed/sold 8,334 options to buy @ $41.52, valued at $346k
Disposed/sold 8,334 options to buy @ $28.44, valued at $237k
Disposed/sold 25,000 options to buy @ $10.44, valued at $261k
Disposed/sold 25,000 options to buy @ $10.56, valued at $264k
Disposed/sold 41,667 options to buy @ $21.06, valued at $877.5k
Disposed/sold 54,167 options to buy @ $6.9, valued at $373.8k
Disposed/sold 51,200 options to buy @ $4.64, valued at $237.6k
Disposed/sold 65,000 options to buy @ $3.99, valued at $259.4k
Disposed/sold 11,300 restricted stock units @ $0
02/02/2018 4 PETERSON SCOTT ROBERT (Chief Scientific Officer) has filed a Form 4 on Cascadian Therapeutics, Inc.
Txns: Granted 155,500 options to buy @ $0
01/16/2018 4 PETERSON SCOTT ROBERT (Chief Scientific Officer) has filed a Form 4 on Cascadian Therapeutics, Inc.
Txns: Paid exercise price by delivering 923 shares @ $3.92, valued at $3.6k
Exercised 2,825 options to buy @ $0
09/20/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/13/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/19/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
12/14/2012 3/A Form 3 - Initial statement of beneficial ownership of securities [amend]
12/14/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
12/11/2012 3 PETERSON SCOTT ROBERT (Chief Scientific Officer) has filed a Form 3 on Oncothyreon Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy